Evelo Biosciences, Inc. (EVLO) Tops Q4 EPS by 7c

Evelo Biosciences, Inc. (NASDAQ: EVLO) reported Q4 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Evelo Biosciences, Inc. (EVLO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• Is the global equity rally broadening? UBS weighs in